Fludarabine

Adult Acute Lymphoblastic Leukemia

Northside Hospital, Inc.Small moleculePhase 4 / ApprovedActive

BBB

75/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 65/ 100
Competitive Position: 89/ 100

Competitive context

65 Active assets in the Adult Acute Lymphoblastic Leukemia cohort.

Asset / Sponsor	Phase	Rating
Mercaptopurine Anhydrous Shanxi Bethune Hospital	Phase 4	A
Methotrexate PETHEMA Foundation	Phase 4	BBB
Cytarabine PETHEMA Foundation	Phase 4	BBB
Cyclophosphamide The First Affiliated Hospital of Zhengzhou University	Phase 4	BBB
Dexasone Shanxi Bethune Hospital	Phase 4	BBB

View all 50 →

Same molecule, other indications

Fludarabine is also rated in:

acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant

BBB

Indicative · Phase 2

76 / 100

adult T-cell leukemia/lymphomaActive

BBB

Indicative · Phase 2

76 / 100

Fanconi anemiaActive

BBB

Indicative · Phase 2/3

76 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.